patented technology to grow and expand adult Stem Cells
Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place
Message: Possible reason for downturn -
KarinCA
|
Friday, 08/15/14 05:55:02 AM | |
| Re: emit post# 3806 | ||
| Post # of 3808 |
A Phase II, Randomized, Double-Blind, Multicenter, Multinational, Placebo-Controlled, Parallel- Groups Study to Evaluate the Safety and Efficacy of Intramuscular Injections of Allogeneic PLX-PAD Cells for the Treatment of Subjects With Intermittent Claudication (IC)
http://clinicaltrials.gov/ct2/show/NCT01679990?term=pluristem&rank=4
Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)
Many are probably out until the completion date is closer.
http://clinicaltrials.gov/ct2/show/NCT01679990?term=pluristem&rank=4
Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)
Many are probably out until the completion date is closer.
New Message
Please
login
to post a reply